Papers
2
Total Citations
13
H-Index
2
About
Carmine Franzese is a surgical oncologist whose research focuses on advancing the surgical management of urologic malignancies, particularly prostate and bladder cancers. His work bridges the gap between oncological efficacy and functional preservation, with a special emphasis on the prognostic significance of unconventional prostate cancer histology. In his landmark 2024 international multicenter study, Franzese demonstrated that variant histology in localized prostate cancer independently predicts worse oncological and functional outcomes following robotic radical prostatectomy, a finding with direct implications for treatment planning and patient counseling. His 2025 investigation into robot-assisted radical cystectomy (RARC) provides crucial evidence that high-volume centers can safely transition from open to robotic approaches without compromising perioperative outcomes, offering a roadmap for institutions considering this technically demanding procedure. With accumulating citations reflecting growing clinical interest, Franzese’s work is shaping evidence-based surgical decision-making in urologic oncology. His contributions are particularly valuable for surgeons and trainees navigating the complexities of robotic surgery, as he systematically evaluates both the benefits and challenges of minimally invasive techniques in the treatment of aggressive urologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2